SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950159-14-000013
Filing Date
2014-01-09
Accepted
2014-01-09 14:28:36
Documents
1
Group Members
QUAKER BIOVENTURES CAPITAL II L.P.QUAKER BIOVENTURES CAPITAL II LLC

Document Format Files

Seq Description Document Type Size
1 QUAKER BIOVENTURES II, L.P. FORM SC 13-G quakerii13g.htm SC 13G 117087
  Complete submission text file 0000950159-14-000013.txt   118805
Mailing Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Subject) CIK: 0001411879 (see all company filings)

IRS No.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87796 | Film No.: 14518437
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Filed by) CIK: 0001497725 (see all company filings)

IRS No.: 205328033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G